Results 191 to 200 of about 71,405 (265)

Prediction of lymphocyte‐predominant breast cancer using microRNA expression in cytology specimens

Cancer Cytopathology, Volume 134, Issue 6, June 2026.
Abstract Background Tumor‐infiltrating lymphocytes are prognostic and predictive biomarkers of breast cancer; however, conventional assessment is hindered by invasiveness and subjective evaluation, limiting clinical reproducibility. This study investigated the utility of microRNA (miRNA) profiles in predicting lymphocyte‐predominant breast cancer (LPBC)
Azusa Kai, Koji Arihiro, Hideo Shigematsu, Yukari Ohue‐Uchihata, Momoko Nakamura, Ai Amioka, Shinsuke Sasada, Morihito Okada   +7 more
wiley   +1 more source

Understanding Equity in Cancer Prehabilitation Services in Wales: A Medical Record Review

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Cancer prehabilitation prepares people for cancer treatment by promoting physical activity, eating well and emotional wellbeing. Evidence shows that prehabilitation before and during cancer treatment reduces treatment complications and improves outcomes, including survival.
Shea Palmer, Alexandra Mitchell, Akhilesh Ramachandran, Nichola Gale, Sian Lewis, Manasi Patil, Nicholas Courtier, Jane Hopkinson   +7 more
wiley   +1 more source

Pharmacokinetic Drug–Drug Interaction Potential of Oral Anticancer Drugs

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1614-1627, June 2026.
Drug–drug interaction (DDI) management is critical for safe and effective use of oral anticancer drugs (OADs). Our study objectives were to (i) compile clinically relevant pharmacokinetic (PK) DDI mechanisms for OADs and (ii) assess the prevalence of PK potential DDIs (PDDIs) in patients with advanced solid cancers.
Fatimah Alhurayri, Islam R. Younis, Shadia I. Jalal, Theodore F. Logan, Rohan Maniar, Steven M. Bray, Sara K. Quinney, Zeruesenay Desta, Todd C. Skaar, James E. Tisdale, Tyler Shugg   +10 more
wiley   +1 more source

Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitis. [PDF]

Intern Med J
Zhang GD, Attree C, Irani N, Tibballs J, Ferguson J, Bertot LC, Wallace M, Smith B, Garas G, Jeffrey G, Adams LA, MacQuillan G.   +11 more
europepmc   +1 more source

Cuproptosis‐Related Genes in Immune Infiltration and Diagnosis in Hepatitis B Virus‐Related Acute Liver Failure

Exploration, Volume 6, Issue 3, June 2026.
The role of cuproptosis in HBV‐ALF was explored via bioinformatics and liver biopsy tissues. There are some crosstalks among cuproptosis, immune infiltration, and ferroptosis (The figure was created by Bio Render). ABSTRACT Hepatitis B virus (HBV) infection poses a significant challenge to global health, particularly in developing countries such as ...
Jingwen Deng, Tao Zhu, Yueyang Wang, Sitong Zhang, Hong Deng, Guilan Quan, Tingting Peng, Chuanbin Wu, Huiqiang Cai, Chao Lu, Xiaopeng Cai   +10 more
wiley   +1 more source

Combined hepatocellular-cholangiocarcinoma: A rare and challenging diagnostic entity - A Case Report. [PDF]

Oncoscience
Limaiem F, Hadrich Z, Atallah A, Hajri M, Omrani S.   +4 more
europepmc   +1 more source

Integrative Bioinformatics Analysis Reveals COL13A1 and COL23A1 as Potential Diagnostic and Prognostic Biomarkers in Thyroid Cancer

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Introduction Thyroid cancer, the most prevalent endocrine malignancy globally, poses challenges owing to the limited understanding of its molecular drivers. Previous research has highlighted collagen genes, such as COL13A1 and COL23A1, as key players in thyroid cancer.
Md. Wahidul Islam, Md. Minhajur Rahman, Homaira Naznin, Md. Shohel Hossain, Tahmina Akter, Zayeda Akter Shatabde, Md. Jubayer Hossain   +6 more
wiley   +1 more source

PET/CT and PET/MRI in Cancer Diagnosis and Management: A Comparative Clinical Perspective

iMetaMed, Volume 2, Issue 2, June 2026.
This review compares PET/CT and PET/MRI in cancer imaging, highlighting their complementary roles for precise diagnosis and staging. It evaluates their technical strengths, clinical performance across various cancers, and future directions, including AI and novel tracers.
Zijian Ding, Ran Xue, Qianxi Jin, Wangzheqi Zhang, Yali Wu, Baixuan Xu   +5 more
wiley   +1 more source

A case of synchronous double primary combined hepatocellular-cholangiocarcinoma complicated with gallbladder adenocarcinoma: a rare case report. [PDF]

Front Oncol
Wang X, Yang L, Jian H, Gao X, Liu T.
europepmc   +1 more source

Integrin α5β1‐mediated multicellular crosstalk in the tumor microenvironment drives bladder cancer progression and reveals targetable vulnerabilities

iMetaOmics, Volume 3, Issue 2, June 2026.
Integrating multiplexed immunofluorescence, animal models, and clinical samples, our single‐cell and spatial atlas maps tumor microenvironment evolution during bladder cancer (BCa) progression. We reveal that stemness‐associated tumor cells (SDC1+), POSTN+ myofibroblastic cancer‐associated fibroblasts (mCAFs), and immunosuppressive monocytic myeloid ...
Ting Liang, Wuwu Xu, Hu Fang, Lu Fu, Dashi Deng, Chenchen Li, Lisha Liu, Dongdong Tang, Huancheng Yang, Fang Liu, Xing Xiong, Guangzhi Li, Song Wu, Tao Tao   +13 more
wiley   +1 more source